Effect of donor risk index on early prognosis of liver transplantation for acute-on-chronic liver failure: experience of 159 cases in one single center
-
摘要:
目的 探讨供体的供体风险指数(DRI)对慢加急性肝衰竭(ACLF)行肝移植治疗早期预后的影响。 方法 回顾性分析接受肝移植治疗的159例ACLF受体临床资料,根据供体DRI计算公式将受体分为DRI < 1.65组(96例)和DRI≥1.65组(63例);根据慢性肝衰竭联盟-慢加急性肝衰竭评分(CLIF-C ACLFs),将受体分为CLIF-C ACLFs < 48组(78例)和CLIF-C ACLFs≥48组(81例)。分别观察各组受体肝移植术后早期预后指标[重症监护室(ICU)住院时间、术后住院时间]。应用Kaplan-Meier生存曲线分析受体肝移植术后90 d生存率,应用Cox比例风险回归模型分析影响ACLF受体肝移植术后早期预后的危险因素。 结果 DRI < 1.65组与DRI≥1.65组的ICU住院时间、术后住院时间比较,差异均无统计学意义(均为P > 0.05)。CLIF-C ACLFs<48组和CLIF-C ACLFs≥48组术后住院时间比较,差异无统计学意义(P > 0.05)。CLIF-C ACLFs < 48组的ICU住院时间为4(3~14)d,明显短于CLIF-C ACLFs≥48组的7(1~33)d(P < 0.05)。CLIF-C ACLFs评分是影响ACLF受体肝移植术后早期预后的危险因素(P < 0.05)。DRI < 1.65组与DRI≥1.65组的术后90 d生存率比较,差异无统计学意义(P > 0.05),CLIF-C ACLFs < 48组受体术后90 d生存率为94%,明显高于CLIF-C ACLFs≥48组的79%(P < 0.05)。 结论 ACLF受体肝移植术后早期预后与其自身病情严重程度相关,而与选用供体的DRI无明显相关性,应早期及时行肝移植治疗。 -
关键词:
- 慢加急性肝衰竭 /
- 肝移植 /
- 供体风险指数 /
- 慢性肝衰竭联盟-器官衰竭评分 /
- 慢性肝衰竭序贯器官衰竭评估评分 /
- 慢性肝衰竭联盟-慢加急性肝衰竭评分
Abstract:Objective To evaluate the effect of donor risk index (DRI) on the early prognosis of liver transplantation for acute-on-chronic liver failure (ACLF). Methods Clinical data of 159 ACLF recipients undergoing liver transplantation were retrospectively analyzed. According to the calculation formula of DRI, all recipients were divided into DRI < 1.65 group (n=96) and DRI≥1.65 group (n=63). Based on the Chronic Liver Failure Consortium acute-on-chronic liver failure score (CLIF-C ACLFs), all recipients were divided into CLIF-C ACLFs < 48 group (n=78) and CLIF-C ACLFs≥48 group (n=81). The early prognosis indexes including the length of intensive care unit (ICU) stay and the length of postoperative hospital stay of the recipients in each group were observed after liver transplantation. The 90 dsurvival rate of the recipients after liver transplantation was analyzed by Kaplan-Meier survival curve. The risk factors affecting the early prognosis of ACLF recipients after liver transplantation were analyzed by Cox's hazards regression model. Results The length of ICU stay and the length of postoperative hospital stay did not significantly differ between the DRI < 1.65 group and DRI≥1.65 group (both P > 0.05). The length of postoperative hospital stay did not significantly differ between the CLIF-C ACLFs < 48 group and CLIF-C ACLFs≥48 group (P > 0.05). The length of ICU stay in the CLIF-C ACLFs < 48 group was 4 (3-14) d, significantly shorter than 7 (1-33) d in the CLIF-C ACLFs≥48 group (P < 0.05). The CLIF-C ACLFs was a risk factor of the early prognosis of ACLF recipients after liver transplantation (P < 0.05). The postoperative 90 d survival rate did not significantly differ between the DRI < 1.65 group and DRI≥1.65 group (P > 0.05). The postoperative 90 d survival rate in the CLIF-C ACLFs < 48 group was 94%, significantly higher than 79% in the CLIF-C ACLFs≥48 group (P < 0.05). Conclusions The early prognosis of ACLF recipients after liver transplantation is correlated with the severity of the disease rather than the DRI. Liver transplantation should be performed early and promptly. -
表 1 ACLF受体早期预后的多因素分析
Table 1. Multivariate analysis of early prognosis of ACLF recipients
影响因素 回归系数(β) 标准误(SE) Wald值 P值 相对危险度 受体 年龄 0.002 0.037 0.004 0.952 1.002 MELD评分 —0.038 0.041 0.883 0.347 0.962 Child-Pugh评分 —0.012 0.292 0.002 0.968 0.988 CLIF-SOFAs评分 0.012 0.194 0.004 0.952 1.012 CLIF-C OFs评分 —0.335 0.365 0.846 0.358 0.715 CLIF-C ACLFs评分 0.188 0.071 7.005 0.008 1.207 供体 BMI 0.055 0.091 0.360 0.548 1.056 死因 0.791 0.512 2.386 0.122 2.205 -
[1] PEZZATI D, HASSAN A, BUCCINI L, et al. Liver transplantation with geriatric liver allograft in the US: a matter of epidemiology or outcome requirements? [J]. Transpl Int, 2017, 30(11):1190-1191. DOI: 10.1111/tri.13013. [2] JALAN R, GINES P, OLSON JC, et al. Acute-on chronic liver failure[J]. J Hepatol, 2012, 57(6):1336-1348. DOI: 10.1016/j.jhep.2012.06.026. [3] MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144(7):1426-1437. DOI: 10.1053/j.gastro.2013.02.042. [4] FENG S, GOODRICH NP, BRAGG-GRESHAM JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index[J]. Am J Transplant, 2006, 6(4):783-790. doi: 10.1111/j.1600-6143.2006.01242.x [5] ARROYO V. Acute-on-chronic liver failure in cirrhosis requires expedited decision for liver transplantation[J]. Gastroenterology, 2019, 156(5):1248-1249. DOI: 10.1053/j.gastro.2019.03.004. [6] 邓斐文, 陈焕伟, 甄作均.公民逝世后器官捐献供肝肝移植单中心经验总结[J].器官移植, 2017, 8(6):435-439. DOI: 10.3969/j.issn.1674-7445.2017.06.005.DENG FW, CHEN HW, ZHEN ZJ. Liver transplantation from donor liver of organ donation after citizens' death: a single center experience[J]. Organ Transplant, 2017, 8(6):435-439. DOI: 10.3969/j.issn.1674-7445.2017.06.005. [7] HUEBENER P, STERNECK MR, BANGERT K, et al. Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival[J]. Aliment Pharmacol Ther, 2018, 47(11):1502-1510. DOI: 10.1111/apt.14627. [8] ZEYTUNLU M, UĞUZ A, ÜNALP Ö, et al. Results of 1001 liver transplantations in 23 years: Ege University experience[J]. Turk J Gastroenterol, 2018, 29(6):664-668. DOI: 10.5152/tjg.2018.18058. [9] JALAN R, SALIBA F, PAVESI M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure[J]. J Hepatol, 2014, 61(5):1038-1047. DOI: 10.1016/j.jhep.2014.06.012. [10] LI N, HUANG C, YU KK, et al. Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: the CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF[J]. Medicine (Baltimore), 2017, 96(17):e6802. DOI: 10.1097/MD.0000000000006802. [11] SZYMCZAK M, KALICIŃSKI P, KOWALEWSKI G, et al. Combined liver-kidney transplantation in children: single-center experiences and long-term results[J]. Transplant Proc, 2018, 50(7):2140-2144. DOI: 10.1016/j.transproceed.2018.04.061. [12] BONNEY GK, ALDERSLEY MA, ASTHANA S, et al. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience[J]. Transplantation, 2009, 87(12):1858-1863. DOI: 10.1097/TP.0b013e3181a75b37. [13] BIGGINS SW, GRALLA J, DODGE JL, et al. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index[J]. Am J Transplant, 2014, 14(11):2588-2594. DOI: 10.1111/ajt.12867. [14] CHOLONGITAS E, THEOCHARIDOU E, VASIANOPOULOU P, et al. Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure[J]. Liver Transpl, 2012, 18(4):405-412. DOI: 10.1002/lt.23370. [15] CHOUDHARY NS, SARAF N, SAIGAL S, et al. Liver transplantation for acute on chronic liver failure[J]. J Clin Exp Hepatol, 2017, 7(3):247-252. DOI: 10.1016/j.jceh.2017.08.001. [16] PAMECHA V, KUMAR S, BHARATHY KG. Liver transplantation in acute on chronic liver failure: challenges and an algorithm for patient selection and management[J]. Hepatol Int, 2015, 9(4):534-542. DOI: 10.1007/s12072-015-9646-9. [17] LI H, CHEN LY, ZHANG NN, et al. Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B[J]. Sci Rep, 2016, 6:25487. DOI: 10.1038/srep25487. [18] HARRING TR, NGUYEN NT, COTTON RT, et al. Liver transplantation with donation after cardiac death donors: a comprehensive update[J]. J Surg Res, 2012, 178(1):502-511. DOI: 10.1016/j.jss.2012.04.044.